Delivery Order SPE2DB22D2005-SPE2DB25FJPN6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,812.63, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,376,424 units of Gentamicin 800 mg/20 ml vial, with a total ceiling value of $11,590.12. The contract is a Delivery Order, with a Firm Fixed Price pricing type, placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Gentamicin 800 mg/20 ml vial, a pharmaceutical product, with a ceiling value of $3,974.46. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The $4,098.33 firm fixed price delivery order is for the supply of 4,564,015,155 units of the pharmaceutical product Gentamicin 800 mg/20 ml vial, with a completion date of March 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as...
- This is a $1,408.05 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4568742299 - GENTAMICIN 2ML 25S, a medical product. The contract is not designated as a set-aside and has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gentamicin 800 mg/20 ml vials, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,601.05 and a completion date of July 10, 2025. It is not a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor and there are no...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gentamicin Pediatric 20 mg/2 ml vials, with a ceiling value of $2,863.71 and a performance period ending on June 10, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $1,401.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract, with a firm fixed price pricing type, and an ultimate completion date of December 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,638.42 firm fixed price delivery order is for the supply of 4.5 gram vials of the antibiotic Piperacil-Tazobact. The contract is non-set-aside and has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award is for $5,739.08 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJPN6Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,324.82 for the delivery of GENTAMICIN 800 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The contract award does not indicate the use of any set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/8/25 |